Reshape Biotech

Reshape Biotech, established in 2018 and headquartered in Copenhagen, Denmark, is at the forefront of laboratory automation, specializing in integrating artificial intelligence and robotics to enhance research and development processes in biotechnology. Their mission centers on providing scientists with advanced tools that automate repetitive tasks, streamline data collection, and deliver precise insights, thereby accelerating scientific discoveries.

The company's flagship offerings include a connected platform of intuitive devices and AI-driven analysis tools. These devices capture high-quality data and instantly transmit it to the cloud, where real-time AI analysis begins immediately. This seamless integration allows for automated imaging and analysis throughout incubation, resulting in faster outcomes, elimination of manual labor, and improved data quality. By automating plate-based assays, applying AI-powered analysis, and achieving reproducibility at scale, Reshape Biotech enables laboratories to focus on critical research while the system manages data collection and analysis.

Reshape Biotech's solutions cater to various industries, including agriculture, industrials, food and ingredients, and personal care and cosmetics. Their technology facilitates automated competition assays for pesticide development, high-throughput microbial discovery, functional ingredient characterization, and product quality testing, among other applications. By standardizing experiments across sectors, Reshape Biotech provides a unified platform that enhances efficiency and collaboration in scientific research.

The company's impact is evident in its collaborations with leading organizations. For instance, Chr. Hansen, a global bioscience company, reported a 400% increase in throughput with accurate AI analysis using Reshape Biotech's platform. Similarly, DTU Biosustain's Genome Engineering Group highlighted the platform's ability to provide deep insights, facilitating the discovery of new phenomena more rapidly.

Reshape Biotech's commitment to innovation and excellence has attracted significant investment, including backing from Y Combinator and other prominent investors. Their interdisciplinary team, comprising experts in microbiology, computer vision, hardware, and software development, collaborates closely to redefine laboratory workflows and set new standards in lab automation and software.

By combining automation with real-time AI analysis, Reshape Biotech empowers laboratories to operate more efficiently, make informed decisions, and scale their operations effortlessly, ultimately contributing to advancements in biotechnology and related fields.